ChinaBio(R) Inaugural Partnering Forum Scheduled for June 2009 in Shanghai, China
SHANGHAI, Nov. 20 /PRNewswire-AsiaNet/ --
Emerging Chinese Biotechs Set to Meet with Global Pharma and Biotech Companies
ChinaBio(R) Accelerator today announced it is organizing the first partnering forum focused on China
life science technology to be held in China. The ChinaBio(R) Partnering Forum, scheduled for June 3 and
4, 2009 in Shanghai, will bring together more than 300 attendees seeking to enter into partnership deals.
The two-day forum will feature one-on-one partnering meetings, technology presentations by China-based
researchers and biotech companies, big pharma leaders discussing their "wish lists," executive workshops
and exhibits.
Technology areas represented will include: novel targets, leads and molecules, biomarkers,
diagnostics, drug development platforms, drug delivery systems and medical devices. All technologies
will be pre-screened by ChinaBio(R) to ensure the highest quality presentations and partnering
opportunities.
To date, ChinaBio(R)-produced events have helped early and mid-stage biotech companies in China to
access over $60 million US and close partnering deals with leading pharmaceutical companies including
Pfizer, Roche, Lilly and Merck.
"China is the fastest growing market for pharmaceuticals in the world and now is transforming itself into
an internationally-recognized leader in biotech innovation," said Greg Scott, President and founder of
ChinaBio(R). "China biotech is clearly poised for global success because of its significant
number of highly skilled scientists and innovators coupled with strong government support and a unique
low cost, high quality development structure. We are now very pleased to announce our first Partnering
Forum to be held in China and look forward to expanding on the success of our prior events here."
More details on the ChinaBio(R) Partnering Forum are available on the website
About ChinaBio(R) Accelerator
ChinaBio(R) Accelerator is an operating unit of ChinaBio(R) LLC, which has offices in Shanghai, Palo
Alto, California, and San Diego, California. The organization is committed to furthering opportunities for
the emerging Chinese biotech industry by funding and mentoring early stage China-based life science
companies, and leveraging its established cross-borders life science network to help companies secure
high value partnerships and make the transition to the global market. For further information:
Contacts:
ChinaBio(R) Accelerator
Greg Scott
858.866.9309
gscott@chinabiollc.com
For ChinaBio(R) Accelerator
Jennifer Larson
415.725.2017
jlarson@labfive.com
SOURCE: ChinaBio(R)
CONTACT: Greg Scott, ChinaBio(R) Accelerator,
+1-858-866-9309, gscott@chinabiollc.com;
Jennifer Larson, +1-415-725-2017, jlarson@labfive.com,
for ChinaBio(R) Accelerator
NEWS 
